Drug intelligence / Profile preview

anti-gamma-delta TCR antibody

Development stage
Unknown
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous, Subcutaneous, Intraperitoneal, Intramuscular, Parenteral
01

Overview

An anti-gamma-delta TCR antibody is a monoclonal antibody designed to target the gamma-delta T-cell receptor (γδ TCR) on the surface of gamma-delta T cells. γδ T cells are a unique subset of T lymphocytes that bridge innate and adaptive immunity, playing critical roles in tumor surveillance, mucosal defense, and autoimmune regulation. Depending on the specific clone and context, anti-γδ TCR antibodies can be used to deplete γδ T cells in vivo, block their activation, or conversely, stimulate their proliferation and effector functions for cancer immunotherapy. These antibodies are widely utilized as research reagents in preclinical models of cancer, infection, and autoimmunity, and are also being explored as therapeutic platforms to redirect γδ T-cell cytotoxicity against tumors.

Other names
anti-gamma-delta T-cell receptor antibodyanti-gamma/delta T-cell receptor antibodyanti-gamma/delta TCR antibodyanti-γδ T-cell receptor antibodyanti-γδ TCR antibody
02

Targets

γδ TCR (T-cell receptor)

Beyond the preview

Go deeper on anti-gamma-delta TCR antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-gamma-delta TCR antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call